XNCR·Xencor, Inc.
XNCR|Fundamentals
XNCR|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-0.40 | - | - |
| Q3'25 | $-0.70 | $-0.08 | +88.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $58M | - | - |
| Q3'25 | - | $21M | - |
XNCR|Monthly Returns
Market Data
XNCR Stock Snapshot
- Market cap
- 1.81B
- Day range
- $0.00 – $0.00
XNCR's technical picture is constructive, with trend and momentum pointing the same direction. At this size, a single catalyst moves the stock further than it would a larger peer.
Sector Rotation
Is money rotating into or out of XNCR's sector?
Xencor, Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, XNCR ranks 13th of 15 tracked industries, lagging.
- Sector rank
- #3 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #13 of 15
Corporate Stakes
Which companies own a stake in XNCR?
Johnson & Johnson reports a stake in Xencor, Inc. on SEC Form 13F: 748.1K shares, about 0.94% of the company, worth $12.0M at the end of Q2 2026. At today's price that stake is worth $17.1M, about 0.00% of JNJ's own market value.
- Holder
- JNJ
- Shares held
- 748.1K
- Stake
- 0.94%
- Value
- $12.0M
Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it.
News & sentiment
What is the news saying about XNCR?
XNCR fell 3.6% over the month to Oct 16.
- Sep 28 +7.6%
- Oct 6 -5.2%
- Oct 13 -5.4%
Technical analysis
How strong is XNCR's momentum right now?
On the daily chart XNCR ranks at the 91st percentile for momentum against the stocks and ETFs DailyIQ tracks, a bullish reading.
Institutional ownership
Are big funds buying or selling XNCR?
33 of the 72 tracked managers added to XNCR in their latest 13F and 30 trimmed. Together they own 40.9% of the company, worth $509.3M. PRIMECAP Management and State Street alone hold 19.1%.
- 1PRIMECAP Management Co12.84%$163.9M positionTrimmed 1.5% last quarter
- 2State Street Corp6.25%$79.8M positionAdded 13.8% last quarter
- $52.8M positionAdded 5.7% last quarter
- $35.7M positionTrimmed 36.7% last quarter
- 5UBS Group AG1.65%$21.0M positionAdded 20.7% last quarter
- 6Baker Bros. Advisors LP1.39%$17.7M positionUnchanged last quarter
- $17.6M positionAdded 2.3% last quarter
- $16.3M positionTrimmed 21.9% last quarter
- $46.3K positionAdded 704.8K shares last quarter
- $11.4M positionAdded 1.5% last quarter
Discover more
How has XNCR done against its peers?
Over the month to Oct 16, XNCR returned −3.5%. Of the 15 related stocks and ETFs, 11 did better, led by MRNA at +51.2%.
- 1MRNAModerna, Inc.up 51.2%+54.8 pts
- 2AMGNAmgen Inc.up 14.9%+18.5 pts
- 3BIIBBiogen Inc.up 7.6%+11.2 pts
- 4GILDGilead Sciences, Inc.up 6.8%+10.3 pts
- 5UTHRUnited Therapeutics Corporationup 6.5%+10.1 pts
- 6XLVHealth Care Select Sector SPDR Fundup 5.2%+8.8 pts
- 7RPRXRoyalty Pharma plcup 4.6%+8.2 pts
- 8REGNRegeneron Pharmaceuticals, Inc.up 1.9%+5.5 pts
- 12XNCRThis stockdown 3.5%
- 16ROIVRoivant Sciences Ltd.down 15.2%−11.6 pts